131 related articles for article (PubMed ID: 26574146)
1. Impact of physiological, pathological and environmental factors on the expression and activity of human cytochrome P450 2D6 and implications in precision medicine.
He ZX; Chen XW; Zhou ZW; Zhou SF
Drug Metab Rev; 2015; 47(4):470-519. PubMed ID: 26574146
[TBL] [Abstract][Full Text] [Related]
2. Farnesoid X Receptor Agonist Represses Cytochrome P450 2D6 Expression by Upregulating Small Heterodimer Partner.
Pan X; Lee YK; Jeong H
Drug Metab Dispos; 2015 Jul; 43(7):1002-7. PubMed ID: 25926433
[TBL] [Abstract][Full Text] [Related]
3. Altered expression of small heterodimer partner governs cytochrome P450 (CYP) 2D6 induction during pregnancy in CYP2D6-humanized mice.
Koh KH; Pan X; Shen HW; Arnold SL; Yu AM; Gonzalez FJ; Isoherranen N; Jeong H
J Biol Chem; 2014 Feb; 289(6):3105-13. PubMed ID: 24318876
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte nuclear factor (HNF) 4α transactivation of cytochrome P450 (Cyp) 2d40 promoter is enhanced during pregnancy in mice.
Ning M; Koh KH; Pan X; Jeong H
Biochem Pharmacol; 2015 Mar; 94(1):46-52. PubMed ID: 25598084
[TBL] [Abstract][Full Text] [Related]
5. Estrogen-Induced Cholestasis Leads to Repressed CYP2D6 Expression in CYP2D6-Humanized Mice.
Pan X; Jeong H
Mol Pharmacol; 2015 Jul; 88(1):106-12. PubMed ID: 25943116
[TBL] [Abstract][Full Text] [Related]
6. Substrate specificity, inhibitors and regulation of human cytochrome P450 2D6 and implications in drug development.
Zhou SF; Liu JP; Lai XS
Curr Med Chem; 2009; 16(21):2661-805. PubMed ID: 19601803
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional Regulation of CYP2D6 Expression.
Pan X; Ning M; Jeong H
Drug Metab Dispos; 2017 Jan; 45(1):42-48. PubMed ID: 27698228
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphism of hepatocyte nuclear factor-4alpha influences human cytochrome P450 2D6 activity.
Lee SS; Cha EY; Jung HJ; Shon JH; Kim EY; Yeo CW; Shin JG
Hepatology; 2008 Aug; 48(2):635-45. PubMed ID: 18666237
[TBL] [Abstract][Full Text] [Related]
9. Effects of Fenofibrate on the Expression of Small Heterodimer Partner (SHP) and Cytochrome P450 (CYP) 2D6.
Kent R; Jeong H
Drug Metab Lett; 2017 Nov; 11(1):68-72. PubMed ID: 28403802
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphism in cytochrome P450 2D6 (CYP2D6): Population distribution of CYP2D6 activity.
Neafsey P; Ginsberg G; Hattis D; Sonawane B
J Toxicol Environ Health B Crit Rev; 2009; 12(5-6):334-61. PubMed ID: 20183526
[TBL] [Abstract][Full Text] [Related]
11. Determinants of Cytochrome P450 2D6 mRNA Levels in Healthy Human Liver Tissue.
Ning M; Duarte JD; Stevison F; Isoherranen N; Rubin LH; Jeong H
Clin Transl Sci; 2019 Jul; 12(4):416-423. PubMed ID: 30821899
[TBL] [Abstract][Full Text] [Related]
12. Cholic Acid Feeding Leads to Increased CYP2D6 Expression in CYP2D6-Humanized Mice.
Pan X; Kent R; Won KJ; Jeong H
Drug Metab Dispos; 2017 Apr; 45(4):346-352. PubMed ID: 28153841
[TBL] [Abstract][Full Text] [Related]
13. Hepatocyte nuclear factors 1α/4α and forkhead box A2 regulate the solute carrier 2A2 (Slc2a2) gene expression in the liver and kidney of diabetic rats.
David-Silva A; Freitas HS; Okamoto MM; Sabino-Silva R; Schaan BD; Machado UF
Life Sci; 2013 Nov; 93(22):805-13. PubMed ID: 24157454
[TBL] [Abstract][Full Text] [Related]
14. Krüppel-like factor 9 promotes hepatic cytochrome P450 2D6 expression during pregnancy in CYP2D6-humanized mice.
Koh KH; Pan X; Zhang W; McLachlan A; Urrutia R; Jeong H
Mol Pharmacol; 2014 Dec; 86(6):727-35. PubMed ID: 25217496
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis of the genetic factors determining expression and function of hepatic CYP2D6.
Zanger UM; Fischer J; Raimundo S; Stüven T; Evert BO; Schwab M; Eichelbaum M
Pharmacogenetics; 2001 Oct; 11(7):573-85. PubMed ID: 11668217
[TBL] [Abstract][Full Text] [Related]
16. Recent examples on the clinical relevance of the CYP2D6 polymorphism and endogenous functionality of CYP2D6.
Haertter S
Drug Metabol Drug Interact; 2013; 28(4):209-16. PubMed ID: 24088607
[TBL] [Abstract][Full Text] [Related]
17. Hepatocyte nuclear factor-4alpha regulates human cellular retinol-binding protein type II gene expression in intestinal cells.
Yamaguchi N; Miyamoto S; Ogura Y; Goda T; Suruga K
Am J Physiol Gastrointest Liver Physiol; 2009 Mar; 296(3):G524-33. PubMed ID: 19147806
[TBL] [Abstract][Full Text] [Related]
18. Novel Independent Trans- and Cis-Genetic Variants Associated with CYP2D6 Expression and Activity in Human Livers.
Smith D; He B; Shi J; Zhu HJ; Wang X
Drug Metab Dispos; 2024 Jan; 52(2):143-152. PubMed ID: 38050015
[TBL] [Abstract][Full Text] [Related]
19. Cytochrome P450 2D6 and Parkinson's Disease: Polymorphism, Metabolic Role, Risk and Protection.
Ur Rasheed MS; Mishra AK; Singh MP
Neurochem Res; 2017 Dec; 42(12):3353-3361. PubMed ID: 28871472
[TBL] [Abstract][Full Text] [Related]
20. The importance of heterogeneous nuclear ribonucleoprotein K on cytochrome P450 2D2 gene regulation: its binding is reduced in Dark Agouti rats.
Sakai N; Sakamoto KQ; Fujita S; Ishizuka M
Drug Metab Dispos; 2009 Aug; 37(8):1703-10. PubMed ID: 19420131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
